| Purpose | Board Meetings Date | Announcement Date |
|---|---|---|
| Board Meeting | 20 May 2026 | 15 May 2026 |
| Audited Results Gujarat Inject Kerala Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 20/05/2026 ,inter alia, to consider and approve 1. Audited Standalone Financial Results of the Company for the quarter & year ended on 31st March, 2026 along with Report of the Statutory Auditors thereon; and 2. Any other business with the permission of the Chair Pursuant to Regulations 30, 33 and other applicable regulations of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby inform that the Board of Directors of GUJARAT INJECT (KERALA) LIMITED [the Company] at its meeting held today i.e. Wednesday 20th May, 2026 has inter-alia discussed, approved, and taken on record the following matter: 1. Approved Audited Financial Results (Standalone) for the Fourth Quarter and year ended on 31st March, 2026. 2. Taking on record Audit Report as issued by M/s. S. Mandawat & Co., Statutory Auditors of the Company. We would like to state that M/s. S. Mandawat & Co. Statutory auditors of the Company, have issued audit reports with unmodified opinion on the Statement. Financial Results for the quarter and year ended on 31/03/2026. (As Per BSE Annoncement Dated on:20.05.2026) | ||
| Board Meeting | 14 Feb 2026 | 11 Feb 2026 |
| Gujarat Inject Kerala Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/02/2026 inter alia to consider and approve Un-Audited Financial Results for the Third Quarter and Nine Months ended on 31st December 2025. As attached (As Per BSE Announcement Dated on:14.02.2026) | ||
| Board Meeting | 13 Nov 2025 | 11 Nov 2025 |
| Quarterly Results-Gujarat Inject Kerala Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/11/2025 ,inter alia, to consider and approve Un-audited Financial Results (Standalone) of the Company for the Quarter and Half year ended on 30th September, 2025, along with Limited Review Report of the Statutory Auditors thereon; UNAUDITED FINANCIAL RESULTS AS ON 30.09.2025 (As per BSE Announcement dated on: 13.11.2025) | ||
| Board Meeting | 30 Oct 2025 | 30 Oct 2025 |
| Outcome of Board Meeting dated Thursday 30th October, 2025 for : 1. Change of place of business where the books of accounts are maintained and ; 2. Change of name of the Company once the name is issued by MCA. | ||
| Board Meeting | 8 Sep 2025 | 8 Sep 2025 |
| Change of Object of the Company. | ||
| Board Meeting | 14 Aug 2025 | 11 Aug 2025 |
| Quarterly Results-Gujarat Inject Kerala Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/08/2025 ,inter alia, to consider and approve Un-Audited Financial Results of the Company for the Quarter ended on 30th June, 2025. FINANCIAL RESULTS 30.06.2025 (As Per BSE Announcement Dated on: 14.08.2025) | ||
| Board Meeting | 7 Jul 2025 | 7 Jul 2025 |
| Outcome of Board Meeting dated 07th July 2025 Revised Outcome of the Board Meeting held on 07th July, 2025. (As Per BSE Announcement Dated on: 25.07.2025) | ||
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132 (Member ID - NSE: 10975 BSE: 179 MCX: 55995 NCDEX: 01249), DP SEBI Reg. No. IN-DP-185-2016, PMS SEBI Regn. No: INP000002213, IA SEBI Regn. No: INA000000623, Merchant Banker SEBI Regn. No. INM000010940, RA SEBI Regn. No: INH000000248, BSE Enlistment Number (RA): 5016, AMFI-Registered Mutual Fund Distributor & SIF Distributor
ARN NO : 47791 (Date of initial registration – 17/02/2007; Current validity of ARN – 08/02/2027), PFRDA Reg. No. PoP 20092018, IRDAI Corporate Agent (Composite) : CA1099

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.